Chimeric Therapeutics Limited CHMMF
0.10 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.001 Day range 0.001
0.001 52-week range 0.10
- YTD
- 0.00%
- 1 year
- 0.00%
News
proactiveinvestors.com Chimeric Therapeutics secures FDA Orphan Drug Designation for CHM CDH17 in gastric cancer Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for its CHM CDH17 cell...
proactiveinvestors.com Imugene secures FDA backing for Azer-cel registration pathway Imugene Ltd (ASX:IMU, OTC:IUGNF) has won crucial backing from the US Food and Drug Administration (FDA), with written minutes from a recent Type C meeting...
proactiveinvestors.com Kairos Minerals secures mining agreement with Nyamal Aboriginal Corporation for Mt York Gold Project Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has signed a Mining Agreement with Nyamal Aboriginal Corporation (NAC) covering the Mt York Gold Project in the...
proactiveinvestors.com Chimeric Therapeutics receives $4.5 million R&D tax incentive refund Chimeric Therapeutics Ltd (ASX:CHM, OTC:CHMMF) has received a research and development (R&D) tax incentive refund of $4,497,886 under the Australian...
proactiveinvestors.com Altech draws interest from top-tier battery manufacturer as Silumina Anodes™ hit 1,000-cycle mark Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) has attracted fresh industry attention after one of the world’s largest electric vehicle battery manufacturers...
proactiveinvestors.com Vaultz completes Xapo Bank onboarding Vaultz Capital PLC (AQSE:V3TC, OTCQB:VZTCF) told investors it has completed onboarding with Xapo Bank, marking the start of a new custody arrangement for...